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Abstract
Hemoglobin A1C measurements are a measure of the average glucose concentrations of a patient
over three months. This measurement helps provide information about one’s diabetic control,
meaning if the A1C is higher, their average blood sugar has been higher over the course of the
past three months. Patients present to providers for preoperative evaluations on a daily basis, and
many of them have diabetes. It is estimated that over 48.3 million elective surgeries are done in
the United States every year (Hall et al., 2017). Preoperative evaluation within 30 days of
surgery is required by most surgeons to better stratify risk versus benefit of the patient’s surgical
outcomes in that specific setting. It is well documented in the literature that a patients A1C does
have an impact on their surgical outcome and overall health status. It is important to understand
their true impact on poor surgical outcomes to provide them with the necessary means to
decrease this risk.
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A1C Measurements Impact on Elective Surgeries
It is estimated that more than 34 million people in the United States have diabetes, and
more than 88 million adults in the United States have prediabetes with 80% of those individuals
not even knowing they have it (CDC, 2019). In 2010, there were over 48.3 billion surgeries done
annually, which accounts for millions of dollars in healthcare spending as well as a large
percentage for one of the many specialties (Hall et al., 2017). Current standard of care is that
patients undergo a preoperative evaluation within 30 days of their surgery. The purpose of this
practice is to ensure that patients are medically optimized for their surgery and thus reduce their
surgical risk. In this paper, I will be discussing a research question and its very own literature
review, as well as the case that this is pertinent too. The case presented in this paper consists of
an elderly woman who presented for a preoperative evaluation for a right knee arthroscopy. Her
primary medical history consisted of diabetes type 2, hypertension, hypothyroid, and obesity. It
was further established that her glycated hemoglobin, or A1C, was 6.2%. Appropriate screening
prior to approval to proceed with surgery is necessary to establish the least amount of risk as
possible, and to also provide the surgeon with appropriate tools to gauge if they want to continue
with the scheduled surgery.
The use of A1C measurements in preoperative evaluations has been studied in the
literature, but the results are not as helpful in the practice setting. Many providers and
associations presume the A1C goal should be less than 7% in higher acuity surgical procedures,
yet there is no clear-cut equation for this. The literature lacks large studies that demonstrate the
ability to have a precise cut off for the A1C goal in the setting of preoperative evaluations. It was
also found in the literature that blood glucose monitoring is more reflective of overall surgical
risk than a target A1C, as blood glucose monitoring shows the current concentration of glucose
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in the blood. The purpose of this paper and research topic is to further establish our basis of A1C
measurements prior to surgical procedures and what this means for outcomes in our patients.
Specifically, a reflection of if a patients A1C is greater than 7% and what that means for their
poor surgical outcomes, versus if it is a rather loose association to the overall risk.
An A1C, or glycosylated hemoglobin, is a blood test that shows what the patients average
blood glucose was over the past three months (American Diabetes Association, 2020). Results of
an A1C less than 5.7% are within normal limits, 5.7-6.4% being prediabetes range, and 6.5% or
greater are within diabetes range. Optimal A1C goals for most individuals with diabetes are less
than 7% unless they are older and other comorbidities, which then their A1C goals are less
stringent because of their hypoglycemia risk. A1C measurements assist providers in assessing
the necessary needs of the patient and how well controlled their diabetes is, as this can impact
outcomes. The most current literature and guidelines relating to diabetic control prior to surgical
procedures as having an A1C measurement less than 7%.
Case Report

Gender: Female
Race: Caucasian
Language: English
Historian: Patient excellent historian
Chief Complaint: Pre-op examination
History of Present Illness: 76-year-old female presents to the clinic for a pre-op exam for her R
knee arthroscopy. She states she had a meniscal tear several months ago and has been having
some pain with this. She states her pain today is 9/10 in the right knee, which is “not bad.” She
takes ibuprofen or Tylenol every day and rotates the two. The date of surgery is not known. She
states her past surgical history is having had a c-section. She denies any complications with
anesthesia. No personal or family history of malignant hyperthermia or bleeding/clotting
disorders. She denies a history of sleep apnea or respiratory disease.
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ASA II Mallampati: 1 METs: 4
Current Medications: Lisinopril 10mg daily, metformin 1000mg twice daily, Rybelsus 7mg
daily, Synthroid 125mcg daily, ASA 81mg daily, APAP 1000mg TID PRN, ibuprofen 600mg
TID PRN
Allergies: Morphine, Amoxicillin
Past Medical History: HTN, hypothyroid, DM 2, obesity, Squamous cell carcinoma
Past Surgical History: c section x2
Family History: Father: Prostate Cancer, HTN Mother: Breast cancer, HTN, obesity MaGr:
Breast cancer
Social History: Lives at home independently. Uses walker or cane to move around. Denies
alcohol and illicit drug use. Smoked tobacco for 20 years- 1ppd, quit 5 years ago.
Review of Systems: No complaints of fever, chills, congestion/runny nose, changes in hearing or
vision, sore throat, cough, shortness of breath, chest pain, weakness, bleeding, or urine/bowel
changes. Denies numbness, tingling, or weakness to upper or lower extremities. Chronic pain to
R knee.
Physical Examination:
Vital Signs: HR 78bpm BP 136/88 R 16 RA 96% T 98.6F Ht 66in Wt 211lbs BMI 34
Constitutional: Oriented x4, well kept
HEENT: Normocephalic. No lymphadenopathy. R TM intact, pearly grey, no erythema. L TM
intact, pearly grey, no erythema. No tonsillar exudate, or redness to oropharynx. Uvula midline.
Cardiovascular: Heart sounds regular, s1 & s2. No murmurs noted. Cap refill <3 sec. No edema
noted.
Respiratory: Lung sounds clear in all fields. No rhonchi, crackles, rales, or wheezes heard.
Musculoskeletal: Pedal and post tib pulses present bilaterally.
Laboratory/Diagnostic Tests: BMP, CBC, A1C, CXR, EKG
Diagnosis/diagnoses:
Preoperative examination
Essential Hypertension
Hypothyroid
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Obesity
Diabetes type 2
Management plan (therapeutic decision making):
A1C: 6.2. CBC, BMP, EKG, CXR to be ordered. Will follow up with results. Educated on medications to
take and not to take the week before surgery. Hold ASA and ibuprofen/NSAIDs for seven days before
surgery. Can take Tylenol up to one day prior to surgery, often given prior to surgery. Take thyroid
medication the morning of surgery. Resume all other medications following surgery. Educated on
advance care planning-should complete prior to surgery. Educated on risks of having surgery- pulmonary
embolism, DVT, heart attack, stroke, death. Educated on post-operative DVT/PE monitoring, making sure
to keep moving, watch bowel movements if taking opioids following surgery. Pt in agreement with plan,
questions answered. Follow up if symptoms or questions arise. OK to proceed with surgery at this time.

Literature Search
The first search was conducted on CINAHL Complete, Health Source - Consumer
Edition, Health Source: Nursing/Academic Edition, and MEDLINE Complete via Ebscohost.
Key words for the search were as follows: (1) “A1C” and (2) “surgery.” The search was
completed using Boolean phrases of the above quoted items, peer reviewed was selected, dates
were altered to 2014-2020, full text was selected, and lastly written in English. The search
resulted in 403 total articles, of which five were pertinent to the posed question with further
review. The second search was conducted on the Pubmed database. Pubmed provides an even
larger foundation of nursing research and general guidelines. A search was conducted with the
key words listed: (1) “A1C” and (2) “surgical outcomes.” The search was further divided into the
past five years publication date, availability of full text, and available in English. The search
yielded 2,196 articles, and only five were prevalent to this research question with further review.
Literature Review and Synthesis of Findings
Current literature clearly documents an increased surgical risk with patients who have
uncontrolled diabetes at the time of surgery. However, this literature is varied in its clinical
recommendations regarding acceptable A1C levels in the setting of proceeding with an elective
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surgery. Every patient’s surgical risk is individual and based on many factors including age, comorbid conditions, type of anesthesia being used, and type of surgical procedure being done.
Underwood et al. (2014) conducted a retrospective study that included 449 patients undergoing
elective procedures with documented A1C measurements prior to their surgery. The article
concluded that A1C measurements greater than 8% were more likely to increase length of stay
and that more studies need to be conducted to assess mortality, infections, renal failure, and
rehospitalization. This is a trend across most of the literature and reflects that A1C measurements
are important in preoperative evaluations but the exact A1C that displaces the risk into a higher
category is unidentified. The conclusions from this article are similar to current standards of care,
however 8% is further from the typical 7% that is recognized and this allows for a larger
interpretation.
Specific to elective surgical procedure risks in the diabetic population, post-operative
infections are of a high concern. It is well documented that patients with diabetes are at an
increased risk of infection due to their elevated blood glucose levels. A pertinent systematic
review and meta-analysis was conducted on diabetic patients and their relation to developing
surgical site infections after undergoing elective procedures (Martin et al., 2016). The results
found that there was a higher risk of surgical site infections in patients with diabetes, which led
to the overall proposal of diabetes being an independent risk factor in the perioperative setting.
However, a specific A1C recommendation was not made from this research. Contrary to that, a
separate retrospective study was done on patients undergoing non-emergent procedures that had
a pre-operative A1C measured, and it was found that infection rates were no different between
the diabetic group and the non-diabetic group (Blankush et al., 2016). It was speculated that risk
factors for post-operative infections are likely synergistic rather than causative simply from
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diabetes. This literature provides the reader with little information on the true impact of A1C
measurements on surgical site infections. Further subgroups and case by case analysis would be
more beneficial in understanding the A1C impact on poor surgical outcomes in each of these
studies, while also demonstrating that diabetes does play a large part in the complete risk for
these patients.
There has also been discussion and literature revolving around blood glucose monitoring
being of higher priority in the perioperative setting when determining a patient’s risk, rather than
focusing on A1C measurements alone. This discussion began with a vast observational cohort
study including 21,541 patients within the Veterans Affair hospital was done that compared the
association between preoperative A1C and early postoperative glucose levels in patients
undergoing elective gastrointestinal surgeries (Jones et al., 2017). This demonstrated a lack of
findings regarding an elevated A1C causing poor surgical outcomes due to the increased blood
glucose monitoring that these patients undergo. Likewise, a systematic review and meta-analysis
was completed on 26,901 patients regarding A1C measurements, perioperative hyperglycemia,
and the predictive nature of periprosthetic joint infection following total joint arthroplasties
(Yang et al., 2017). The study concluded that hyperglycemia and elevated A1C measurements
did in fact increase the risk of periprosthetic joint infections. It was further reiterated that the idea
behind monitoring blood glucose measurement perioperatively is a more predictive and
reflective aid in infection risk instead of relying solely on A1C measurements. Van den Boom et
al. (2018) completed a retrospective analysis on 431,480 surgeries completed at Duke Hospital
and measured the effects of A1C and glucose on postoperative mortality. Their findings were
similar in that glucose measurements perioperatively were more predictive than A1C
measurements when looking at 30-day mortality rates. These articles provide a better basis of

IMPACT OF A1C MEASUREMENTS ON ELECTIVE SURGERIES
10
knowledge concerning where our efforts can impact the patients most. Perioperative blood
glucose monitoring is very common in the surgical setting with patients who have diabetes, and
completely independent of their elective or non-elective surgical status. It would make sense that
perioperative blood glucose control would have the largest impact on poor outcomes in the
setting of elective surgical procedures.
Although previous articles have not determined a specific A1C measurement that
determines complete risk in diabetic patients undergoing elective procedures, there are still
studies that do contain this information. An A1C measurement of 8% was decided to be a
maximum threshold used informally for an independent risk factor in one study relating to
postoperative infections requiring surgical intervention in patients with diabetes who underwent
total knee arthroplasties (Cancienne, Werner, & Browne, 2017). They specified that an A1C goal
of less than 7% did in fact decrease the risk of postoperative infections in this patient subgroup
exclusively. It was also identified that previously completed studies were much smaller in the
number of patients included, which has created a barrier in understanding the true risk of each of
the A1C measurements compared to poor outcomes.
A1C measurements greater than 7% were found to cause a definite increase in surgical
site infection risks (Showen et al., 2017). The general consensus reiterated that perioperative
glucose monitoring was again found to more beneficial in decreasing risk, instead of a sole A1C
focus. A specific study established that having an A1C greater than 6.9% was found to increase
risk of infection rates among patients who underwent a single-level lumbar posterior fusion
(Hwang et al., 2019) However, this study contained only 92 participants, which creates a large
barrier to applying as a guideline with such a small sample size and specific surgical procedure.
Statz et al. (2018) considered outcomes of shoulder arthroplasties of 406 patients and their
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perioperative A1C measurements. Their findings consisted of a poor correlation between A1C
measurements and poor surgical outcomes following shoulder arthroplasties. It was still advised
that this lab be checked and optimized prior to surgery but further studies need to be conducted
to give a clear cut off of A1C goals.
The case study patient presented earlier in the paper had an A1C of 6.2% and was being
managed on metformin and rybelsus. This A1C measurement is very ideal for surgical
optimization reflection purposes. This meant that her diabetes was not interfering with upcoming
surgery by simply relying on this measurement. The findings from the literature review were vast
in nature, yet very similar. Most of the articles found that specific A1C cutoffs were not
necessarily correlating to the measured risks, but elevated A1C’s were contributing to a general
increase of poor surgical outcomes. The A1C levels that were greater than 7% were found to
increase risk, but to what degree still remains to be studied. The literature reiterated that
perioperative glucose monitoring would be the most beneficial to patients, rather than basing it
completely on A1C goals. Further studies need to be conducted to find a correlation between
specific A1C numbers and their results following surgical procedures. A common limitation for
each of the articles was the vast majority of patients have other comorbidities and it is difficult to
pinpoint an A1C measurement as a strict reflection of their poor surgical outcome risk. The most
prevalent risk factor included surgical site infection, which was most often correlated with an
increased A1C. However, glucose monitoring in the perioperative setting will be very beneficial
while awaiting further studies.
Learning Points
•

Perioperative glucose has a much higher predictive clinical value in patients with diabetes
who undergo elective surgical procedures than is reflective of their A1C measurements.
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•

A1C is recommended to be optimized in most situations, with several sources finding
measurements greater than 7% do increase the risk of poor surgical outcomes in elective
procedures. However, the degree of the exact A1C measurement was found to be relative
in that it is not a direct reflection but a contributor to risk.

•

Each patient is an individual and their risks need to be weighed at the time of their office
visit, as well as each surgical procedure carrying their own independent risks.
Conclusion
This paper looked to evaluate what correlation exists between patients with type 2

diabetes and their increased surgical risks if their A1C was >7%. The literature review and
synthesis of findings led to the conclusion that A1C measurements are ideal to be taken prior to
surgery, but the perioperative glucose measurements are much more conducive to decreasing
overall poor surgical outcomes. There is a risk associated with A1C levels greater than 7% in
patients undergoing elective surgical procedures, but the degree of risk if unknown and likely to
be multifactorial. This can impact the future of medicine, yet requires a perioperative plan to be
in place of checking blood sugars to a target goal. The target goal of blood sugars and A1C
measurements in regards to perioperative management have yet to be decided for current
reference, which will require a need for further studies to be conducted.

IMPACT OF A1C MEASUREMENTS ON ELECTIVE SURGERIES
13
References
American Diabetes Association (ADA). (2020). Understanding A1C.
https://www.diabetes.org/a1c
Centers for Disease Control and Prevention (CDC). (2019). Diabetes Quick Facts.
https://www.cdc.gov/diabetes/basics/quick-facts.html
Blankush, J. M., Leitman, I. M., Soleiman, A., & Tran, T. (2016). Association between elevated
pre-operative glycosylated hemoglobin and post-operative infections after non-emergent
surgery. Annals of medicine and surgery (2012), 10, 77–82.
https://doi.org/10.1016/j.amsu.2016.07.025
Cancienne, J. M., Werner, B. C., & Browne, J. A. (2017). Is there an association between
hemoglobin A1C and deep postoperative infection after TKA? Clinical orthopaedics
and related research, 475(6), 1642–1649. https://doi.org/10.1007/s11999-017-5246-4
Hall, M.J., Schwartzman, A., Zhang, J., & Liu, X. (2017). Ambulatory surgery data from
hospitals and ambulatory surgery centers: United States, 2010. National Health Statistics
Reports. https://www.cdc.gov/nchs/data/nhsr/nhsr102.pdf
Hwang, J. U., Son, D. W., Kang, K. T., Lee, S. H., Lee, J. S., Song, G. S., Lee, S. W., & Sung, S.
K. (2019). Importance of hemoglobin A1c levels for the detection of post-surgical
infection following single-level lumbar posterior fusion in patients with diabetes. Korean
journal of neurotrauma, 15(2), 150–158. https://doi.org/10.13004/kjnt.2019.15.e36
Jones, C. E., Graham, L. A., Morris, M. S., Richman, J. S., Hollis, R. H., Wahl, T. S., Copeland,
L. A., Burns, E. A., Itani, K. M. F., Hawn, M. T., & Itani, K. M. (2017). Association
between preoperative hemoglobin A1c levels, postoperative hyperglycemia, and

IMPACT OF A1C MEASUREMENTS ON ELECTIVE SURGERIES
14
readmissions following gastrointestinal surgery. JAMA Surgery, 152(11), 1031–1038.
https://doi-org.ezproxy.library.und.edu/10.1001/jamasurg.2017.2350
Martin, E. T., Kaye, K. S., Knott, C., Nguyen, H., Santarossa, M., Evans, R., Bertran, E., &
Jaber, L. (2016). Diabetes and risk of surgical site infection: A systematic review and
meta-analysis. Infection control and hospital epidemiology, 37(1), 88–99.
https://doi.org/10.1017/ice.2015.249
Showen, A., Russell, T. A., Young, S., Gupta, S., & Gibbons, M. M. (2017). Hyperglycemia is
associated with surgical site infections among general and vascular surgery
patients. American Surgeon, 83(10), 1108–1111.
Statz, J. M., Wagner, E. R., Sperling, J. W., & Cofield, R. H. (2018). Outcomes of shoulder
arthroplasty in diabetic patients as assessed by peri-operative A1C. International
Orthopaedics, 42(8), 1923–1934.
https://doi-org.ezproxy.library.und.edu/10.1007/s00264-018-3874-2
Underwood, P., Askari, R., Hurwitz, S., Chamarthi, B., & Garg, R. (2014). Preoperative A1C
and clinical outcomes in patients with diabetes undergoing major noncardiac surgical
procedures. Diabetes Care, 37(3), 611–616.
https://doi-org.ezproxy.library.und.edu/10.2337/dc13-1929
Van den Boom, W., Schroeder, R. A., Manning, M. W., Setji, T. L., Fiestan, G.-O., & Dunson,
D. B. (2018). Effect of A1C and Glucose on Postoperative Mortality in Noncardiac and
Cardiac Surgeries. Diabetes Care, 41(4), 782–788.
https://doi-org.ezproxy.library.und.edu/10.2337/dc17-2232
Yang, L., Sun, Y., Li, G., & Liu, J. (2017). Is hemoglobin A1c and perioperative hyperglycemia
predictive of periprosthetic joint infection following total joint arthroplasty?: A

IMPACT OF A1C MEASUREMENTS ON ELECTIVE SURGERIES
15
systematic review and meta-analysis. Medicine, 96(51), e8805.
https://doi.org/10.1097/MD.0000000000008805

